×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Artificial Intelligence in the Medicines Lifecycle: Delivering Globally for Public and Animal Health
Session Chair(s)
Representative Invited
European Medicines Agency, Netherlands
Aftificial Intelligence (AI) is being adopted across the medicine lifecycle to increase insights into data and improve efficiency of processes, for the benefit of public and animal health. This session will address key elements to enable the safe and responsible use of AI.
Learning Objective : Explore AI opportunities across the medicine lifecycle; Examine the legal ecosystem of AI across jurisdictions and identify opportunities for convergence; Understand how regulators worldwide are developing guidance to support AI innovation in the medicine lifecycle; Discover other strategic AI initiatives, including approaches to leveraging AI with healthcare data.
Have an account?